Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.
Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs
Snehal S Manekar, Ravindrakumar L Bakal, Ankush R Turankar
Aim of study: Dengue virus (DENV) causes a clinical infection called dengue hemorrhagic fever (DHF). Millions of people are impacted by this condition. However, there is currently no specific medication available to stop it. Despite having recently received approval for use in preventing illness, a vaccination against some dengue virus (DENV) serotypes was proven to be ineffective. Some preventative methods utilizing plant extracts demonstrated some encouraging ovicidal action against Aedes aegypti.
Summary: Some antiviral medications are being tested in clinical settings to treat dengue fever, but the results have not yet been reported or validated. Numerous researches have revealed that the possibility of using compounds with plant origins could be excellent agents for the creation of secure and effective treatments for certain illnesses. This review provides scientifically validated knowledge on plants used in the treatment and management of dengue fever along with phytoconstituents responsible for the activity and type of solvent used to extract it.